Portfolio Management
Before Wednesday’s opening bell, Monsanto (MON) released its second quarter financial results. Here’s what the results mean for mutual fund investors.
Inside MON’s Results
Earnings
The company reported earnings of $1.425 billion, or $2.92 per share, down from $1.670 billion, or $3.15 per share, last year. Analysts expected to see EPS of $2.93.
Revenue
Sales dropped to $5.197 billion from $5.832 billion. Analysts expected to see revenue of $5.58 billion.
U.S. Dollar Pressures
Monsanto is one of the many companies that has seen its profits pressured by the stronger dollar. During the quarter, the company also saw lower production and a 15% decline in profits.
The stock has been mostly flat over the last year, underperfomring its peer as well as the S&P 500.
Mutual Funds To Watch
Investors interested in MON may be interested in the funds listed below. These funds currently have the largest stakes in the company.
| Symbol | Mutual Fund | Stake |
|---|---|---|
| VTSMX | Vanguard Total Stock Market | 1.75% |
| VPMCX | Vanguard PRIMECAP | 1.30% |
| VFINX | Vanguard 500 Index | 1.25% |
The Bottom Line
The funds listed above allow investors to gain exposure to MON while remaining diversified. Investors interested in MON may also be interested in DuPont (DD).
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Sign up for Advisor Access
Receive email updates about best performers, news, CE accredited webcasts and more.
Popular Articles
Practice Management
3 Must Read Pieces for Practice Management: January 13
Download Our Free Report
